{
    "patient": {
        "Name": "Monica Nichols",
        "DateOfBirth": "1958-05-25",
        "Sex": "Male",
        "Diagnosis": "Follicular thyroid cancer",
        "BodyPart": "Thyroid",
        "Physician": "Dr. David Williams",
        "TreatingInstitution": "Hughes Group"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Thyroid",
            "CollectedDate": "2024-04-09",
            "ReceivedDate": "2024-04-10",
            "TumorPercentage": "53%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2024-04-11",
            "ReceivedDate": "2024-04-11"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "PRKCA",
                "DNA Alteration": "c.1387G>C",
                "GeneMutation": "p.D463H Frameshift-LOF",
                "VariantAlleleFraction": "1.91%"
            },
            {
                "Gene": "AKT1",
                "DNA Alteration": "c.49G>A",
                "GeneMutation": "p.E17K Stopgain-LOF",
                "VariantAlleleFraction": "19.48%"
            },
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Nonsense-LOF",
                "VariantAlleleFraction": "25.86%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "SMO",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": " p.W266* Nonsense-GOF",
                "VariantAlleleFraction": "19.68%"
            },
            {
                "Gene": "FLT3",
                "DNA Alteration": "c.2028C>A",
                "GeneMutation": "p.D835X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "18.03%"
            },
            {
                "Gene": "HSD3B1",
                "DNA Alteration": "c.1100C>A",
                "GeneMutation": "p.T367N Nonsense-GOF",
                "VariantAlleleFraction": "10.09%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": []
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "27 m/Mb",
            "Tmbpercentile": "43%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "High"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}